Clinical outcomes | Low GRACE group (N = 88) | Intermediate to high GRACE group (N = 64) | P-value |
---|---|---|---|
In-hospital mortality, n (%) | 0 (0) | 2 (3.1) | 0.095 |
At 1Â month | |||
 Composite outcomes | 2 (2.3) | 10 (15.6) | 0.003 |
 ACS | 1 (1.1) | 1 (1.6) | 0.666 |
 Heart failure | 1 (1.1) | 6 (9.4) | 0.022 |
 Stroke | 0 (0) | 1 (1.6) | 0.421 |
 CV death | 0 (0) | 2 (3.1) | 0.180 |
 Non-CV death | 0 (0) | 0 (0) | NS |
 Loss to follow-up | 2 (2.3) | 2 (3.1) | 0.562 |
At 6Â month (cumulative) | |||
 Composite outcomes | 6 (6.8) | 12 (18.7) | 0.024 |
 ACS | 4 (4.5) | 1 (1.6) | 0.298 |
 Heart failure | 2 (2.3) | 7 (10.9) | 0.036 |
 Stroke | 0 (0) | 2 (3.1) | 0.421 |
 CV death | 0 (0) | 2 (3.1) | 0.175 |
 Non-CV death | 0 (0) | 0(0) | NS |
 Loss to follow-up | 2 (2.3) | 2 (3.1) | 0.562 |